Mounjaro PBS Australia: Is Tirzepatide Covered by the PBS, Onlinepharmaustralia If you are considering Mounjaro (tirzepatide) in Australia, you may be wondering whether the Pharmaceutical Benefits Scheme (PBS) will cover some or all of the cost.
This question is particularly important because Mounjaro has more than one approved medical use, and PBS subsidy depends on the specific indication and applicable government restrictions.
As of the latest Australian Government information available for this article, Mounjaro is not PBS subsidised for the purpose of weight management. People using GLP-1 medicines for weight loss generally need to pay for treatment themselves.
However, this does not mean that Mounjaro has no relationship with the PBS or that its PBS status can never change.
This guide explains what the PBS is, Mounjaro’s current status, the difference between TGA approval and PBS subsidy, and what patients should know about potential costs.
What Is the PBS?
The Pharmaceutical Benefits Scheme, commonly called the PBS, is Australia’s government-funded system for subsidising many prescription medicines.
When a medicine is listed on the PBS and a patient meets the relevant requirements, the government subsidises the cost of the medicine.
The patient generally pays a regulated contribution rather than the full private price. Mounjaro PBS Australia
However, PBS listing does not mean that every patient can automatically receive the medicine at the subsidised price.
There can be specific restrictions relating to:
- The medical condition
- Patient eligibility
- Previous treatments
- Clinical circumstances
- Prescription requirements
- Maximum quantities
- Authority requirements
Therefore, it is important to distinguish between medicine registration and PBS subsidy.
Is Mounjaro on the PBS in Australia?
The answer depends on what you mean by “on the PBS.”
Mounjaro is registered by the TGA for approved medical uses, including chronic weight management and type 2 diabetes.
However, current Australian Government material states that tirzepatide (Mounjaro) is not PBS subsidised for weight loss.
This distinction is important.
A medicine can be approved for a particular medical condition by the TGA without being subsidised by the PBS for that condition.
Is Mounjaro PBS Covered for Weight Loss?
Currently, Mounjaro is not PBS subsidised for weight management.
The Australian Government’s consultation material on equitable access to GLP-1 medicines states that GLP-1 medicines registered for obesity, including Mounjaro, are not currently subsidised through the PBS for the purpose of losing weight.
This means that patients using Mounjaro privately for weight management generally need to pay the cost themselves.
The fact that Mounjaro is TGA-approved for chronic weight management does not automatically make it PBS subsidised for that purpose.
Is Mounjaro PBS Covered for Type 2 Diabetes?
This question requires more care.
Mounjaro is TGA-approved for the treatment of adults with type 2 diabetes in appropriate circumstances.
However, PBS listing and subsidy depend on the current PBS Schedule and applicable restrictions.
Government PBAC documents show that tirzepatide has been considered in relation to potential PBS listing for type 2 diabetes, including proposed restrictions and pricing arrangements. A November 2025 PBAC public summary reported that a submission to list tirzepatide on the PBS for certain type 2 diabetes patients had been deferred while discussions continued regarding restrictions, pricing and financial arrangements.
Therefore, patients should not assume that a Mounjaro prescription for diabetes automatically receives a PBS subsidy.
Always check the current PBS Schedule or ask your pharmacist about the status of your particular prescription.
TGA Approval vs PBS Listing: What’s the Difference?
This is one of the most important concepts to understand.
TGA approval
The Therapeutic Goods Administration assesses medicines for quality, safety and efficacy before they can be registered for approved uses in Australia.
Mounjaro is registered by the TGA and contains tirzepatide.
PBS listing
The PBS determines whether the Australian Government will subsidise a medicine under specified conditions.
A medicine can therefore be:
TGA-approved but not PBS-subsidised for a particular use.
This is why seeing Mounjaro listed on the Australian Register of Therapeutic Goods does not automatically mean you can obtain it at the PBS patient contribution.
Why Isn’t Every Approved Medicine Automatically on the PBS?
PBS listing involves additional considerations beyond regulatory approval.
The Pharmaceutical Benefits Advisory Committee (PBAC) evaluates medicines and considers factors including clinical effectiveness, comparative benefits, safety and cost-effectiveness.
The Australian Government’s 2025 consultation material explains that PBAC advice contributes to government decisions about PBS listing.
The process can therefore involve:
- Clinical evidence
- Comparison with existing treatments
- Cost-effectiveness
- Budget impact
- Proposed patient eligibility
- Restrictions
- Pricing negotiations
Regulatory approval and government subsidy are separate decisions.
Why Is Mounjaro Available Privately?
Because TGA registration allows an approved medicine to be prescribed and supplied through the appropriate Australian healthcare system, even when the government does not subsidise a particular use through the PBS.
If Mounjaro is prescribed appropriately for an indication that is not PBS subsidised, the patient may need to pay the private pharmacy price.
This is particularly relevant for chronic weight management.
How Much Does Mounjaro Cost Without PBS Subsidy?
There is no single permanent private price for Mounjaro across Australia.
The amount you pay can vary according to:
- Strength
- Product presentation
- Pharmacy
- Location
- Availability
- Prescription quantity
- Dispensing arrangements
- Delivery
- Consultation fees
This is why it is better to ask a pharmacy for the current total cost rather than relying on an old online price.
For a broader discussion, see:
Mounjaro Cost Australia: Price, PBS Coverage and What to Expect
Does Having a Medicare Card Make Mounjaro Cheaper?
Not automatically.
Medicare and the PBS are related parts of Australia’s public healthcare system but serve different purposes.
A Medicare card does not mean every prescription medicine is automatically subsidised.
PBS subsidies apply when a medicine is listed and the patient meets the applicable conditions.
If your Mounjaro prescription is not eligible for PBS subsidy, you may still need to pay the private price.
Does Private Health Insurance Cover Mounjaro?
This depends on your individual health-insurance policy.
Private health insurance does not automatically cover every outpatient prescription medicine.
If you have private health insurance, contact your insurer and ask specifically whether your policy provides benefits for the type of prescription medicine you have been prescribed.
Do not assume that because a medicine is expensive it will automatically be covered.
Can a Doctor Prescribe Mounjaro if It Isn’t PBS Subsidised?
Yes, a medicine does not need to be PBS subsidised for a healthcare professional to prescribe it for an approved indication when clinically appropriate.
However, the patient may need to pay the private cost.
A prescription is still required because Mounjaro is a prescription medicine.
The decision to prescribe should be based on clinical appropriateness, not simply on whether a patient is willing to pay.
Can You Get Mounjaro for Weight Management Privately?
Mounjaro has an Australian TGA-approved indication for chronic weight management in eligible adults.
The indication includes adults with:
- A BMI of 30 kg/m² or greater, or
- A BMI of at least 27 kg/m² and less than 30 kg/m² with at least one weight-related comorbid condition.
Treatment is intended to be used alongside a reduced-calorie diet and increased physical activity.
A healthcare professional must determine whether treatment is appropriate for the individual.
Could Mounjaro Become PBS Subsidised for Weight Management?
PBS policy can change over time.
The Australian Government has conducted work examining equitable access to GLP-1 medicines for obesity, including Mounjaro.
However, patients should not assume that a future subsidy will occur or that a proposal automatically means a medicine will be listed.
If PBS status changes, the official PBS Schedule and Australian Government announcements should be treated as the authoritative sources.
What About Mounjaro PBS Applications?
Tirzepatide has been considered through the PBAC process for potential PBS access in type 2 diabetes.
The November 2025 PBAC public summary described consideration of tirzepatide submissions and noted concerns around proposed restrictions, financial arrangements and potential use outside the proposed PBS restrictions. The submission was deferred while further discussions continued.
This illustrates why PBS status can be more complicated than simply asking whether a medicine has been “submitted.”
A submission, PBAC consideration, recommendation and final PBS listing are not necessarily the same thing.
How Can You Check the Current Mounjaro PBS Status?
Because PBS listings can change, use official Australian Government sources when checking current status.
Useful sources include:
- The PBS Schedule
- The Pharmaceutical Benefits Advisory Committee
- The Australian Department of Health and Aged Care
- Your pharmacist
- Your prescribing healthcare professional
Do not rely on an old blog post or social-media post claiming that Mounjaro has become subsidised.
Check the date and source of the information.
What If a Website Says Mounjaro Is “PBS Covered”?
Read the claim carefully.
A website may use “PBS” in a misleading way.
Ask:
- Is the medicine actually listed on the PBS?
- Is the specific indication covered?
- Does the patient meet the restriction?
- Is an authority prescription required?
- Does the claim apply to the current PBS Schedule?
- Is the information dated?
A statement such as “Mounjaro is PBS approved” does not necessarily mean that every patient can obtain Mounjaro at the PBS price.
Mounjaro PBS and Weight Management: What Patients Should Know
If you are considering Mounjaro specifically for weight management, the most important point is straightforward:
Current Australian Government information says Mounjaro is not PBS subsidised for weight loss.
This means you should plan for private treatment costs unless the government announces a change to the subsidy arrangements.
Your healthcare professional can discuss alternative treatments if cost makes Mounjaro unsuitable.
What If You Cannot Afford Mounjaro?
Tell your healthcare professional.
Depending on your circumstances, they may discuss:
- Lifestyle interventions
- Nutrition support
- Exercise programmes
- Other approved medicines
- Management of obesity-related conditions
- Other weight-management strategies
Do not purchase Mounjaro from an unverified source because the legitimate private price is too high.
Prescription-medicine safety should take priority over finding the lowest advertised price.
Mounjaro PBS Australia: Frequently Asked Questions
Is Mounjaro on the PBS in Australia?
Mounjaro is TGA-registered, but current government material states it is not PBS subsidised for weight management. PBS treatment of specific indications should always be checked against the current PBS Schedule.
Is Mounjaro covered by the PBS for weight loss?
No. Current Australian Government consultation material states that Mounjaro is not currently PBS subsidised for the purpose of losing weight.
Is Mounjaro PBS subsidised for diabetes?
The answer depends on the current PBS Schedule and applicable restrictions. Mounjaro is TGA-approved for type 2 diabetes, but TGA approval and PBS subsidy are separate matters.
Does Medicare cover Mounjaro?
Medicare does not automatically subsidise Mounjaro. PBS subsidy depends on the medicine, indication and applicable PBS requirements.
Can I get Mounjaro privately if it isn’t PBS subsidised?
If a healthcare professional determines that Mounjaro is appropriate and issues a valid prescription, it may be supplied privately through an appropriate pharmacy pathway.
Why isn’t every TGA-approved medicine on the PBS?
TGA registration and PBS subsidy involve different assessment processes. PBS listing involves consideration of clinical evidence, comparative benefits, cost-effectiveness, pricing and other factors.
Could Mounjaro become PBS subsidised in the future?
Government policy and PBS listings can change. Any future change should be confirmed through official Australian Government sources.
How can I check whether Mounjaro is currently PBS subsidised?
Check the current PBS Schedule or ask a pharmacist. Use official government information rather than relying on outdated online articles.
Is Wegovy on the PBS?
Current Australian Government consultation material states that GLP-1 medicines registered for weight management, including Wegovy, were not PBS subsidised for weight loss at the time of that consultation.
Does a PBS application mean Mounjaro is already subsidised?
No. A submission or PBAC consideration does not automatically mean a medicine has been listed on the PBS.
Important Safety Information
Mounjaro is a prescription medicine and should only be used under appropriate medical supervision.
The TGA updated the Australian Product Information for tirzepatide in 2026 to include information about the rare eye disorder non-arteritic anterior ischaemic optic neuropathy (NAION). A sudden loss of vision should lead to urgent ophthalmological assessment.
Mounjaro also has specific pregnancy and contraception considerations. The TGA advises that oral contraceptive effectiveness may potentially be reduced for four weeks after starting tirzepatide and for four weeks after each dose escalation, with alternative or additional contraception advised during those periods.
Always use the current Australian Consumer Medicine Information and Product Information for the latest safety information.
The Bottom Line
The key distinction is between TGA approval and PBS subsidy.
Mounjaro is TGA-registered for approved medical uses, including chronic weight management and type 2 diabetes.
However, current Australian Government information states that Mounjaro is not PBS subsidised for weight loss.
For type 2 diabetes, patients should check the current PBS Schedule and applicable restrictions rather than assuming that a Mounjaro prescription automatically qualifies for a PBS subsidy.
Because government policy and medicine listings can change, check official Australian Government sources or speak with your pharmacist for the most current information.
This article is for general educational purposes and does not replace the current PBS Schedule, Australian Product Information, Consumer Medicine Information or personalised medical advice.